Berinert® (C1 esterase inhibitor [human]) – Expanded indication
July 18, 2016 – CSL Behring announced the FDA approval of Berinert (C1 esterase inhibitor [human]) injection, for the treatment of acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in adult and pediatric patients.
Top